News Overview

Business Wire India -Strong Performance Against FY2021 Management Guidance with Underlying Revenue Growth of +7.4% (Reported Revenue Growth +11.6%) and Strength Across Key Business Areas – Highest Total Number of Approvals for Takeda in a Fiscal Year Across Japan (4 NMEs), China (3 NMEs), the U.S. (2 NMEs), and Europe (1 NME) – Robust Free Cash Flow of JPY 943.7 Billion ($7.8B); Net Debt/Adjusted EBITDA […]

The rationale behind expansion is to increase share of high end SKU's.

Gujarat Gas Ltd, SRF Ltd, Team Lease Services Ltd and Elecon Engineering Company Ltd are among the other gainers in the BSEs A group today, 11 May 2022.

On 9 May 2022

To a later date

Indias active caseload currently stands at 19,494. In the last 24 hours, 2,897 new cases and 2,986 recoveries have been recorded. The daily positivity rate is at 0.61%. The recovery rate is currently at 98.74%. So far under Nationwide Vaccination Drive, 190.67 cr vaccine doses have been administered.Powered by Capital Market – Live News

To 18 May 2022

To 18 May 2022

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg (base)/2 ml Unit-dose Vial. The approved ANDA is therapeutically equivalent to the reference listed drug product (RlD), Brovana Inhalation Solution, 15 mcg/2 ml, of Sunovion Pharmaceuticals Inc. Arformoterol Tartarate Inhalation Solution is a longacting […]

To 24 May 2022